| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |